Literature DB >> 17928605

Breast-cancer therapy--looking back to the future.

Anne Moore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928605     DOI: 10.1056/NEJMe078153

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Antiangiogenic therapies in early-stage breast cancer.

Authors:  Christina Derleth; Ingrid A Mayer
Journal:  Clin Breast Cancer       Date:  2010       Impact factor: 3.225

2.  Increased H2O2 level in exhaled breath condensate in primary breast cancer patients.

Authors:  Robert A Stolarek; Elzbieta Potargowicz; Ewa Seklewska; Jarosław Jakubik; Marek Lewandowski; Arkadiusz Jeziorski; Dariusz Nowak
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-05       Impact factor: 4.553

3.  Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1.

Authors:  Zhigang Bai; Zhongtao Zhang; Xiang Qu; Wei Han; Xuemei Ma
Journal:  Oncol Lett       Date:  2011-09-09       Impact factor: 2.967

4.  Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.

Authors:  Paul Ellis; Peter Barrett-Lee; Lindsay Johnson; David Cameron; Andrew Wardley; Susan O'Reilly; Mark Verrill; Ian Smith; John Yarnold; Robert Coleman; Helena Earl; Peter Canney; Chris Twelves; Christopher Poole; David Bloomfield; Penelope Hopwood; Stephen Johnston; Mitchell Dowsett; John M S Bartlett; Ian Ellis; Clare Peckitt; Emma Hall; Judith M Bliss
Journal:  Lancet       Date:  2009-05-16       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.